🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate whether beclomethasone dipropionate / formoterol (BDP/FOR; Fost...
Status
Completed
Location
Multiple Locations
Start Date
2011-01
Trial ID
NCT01908075
A randomised controlled trial to test the hypothesis that inhaled therapies...
Status
Completed
Location
NHS Tayside
Start Date
2016-12
Trial ID
NCT02972476
The aim of this study is to compare the effectiveness of two treatments for...
Status
Unknown
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02270424
The aim of this study is to establish the therapeutic equivalence between t...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT05459194
Treatments Being Tested
Pharmacokinetic study comparing Salmeterol/fluticasone Easyhaler products a...
Status
Completed
Location
Orion Pharma pharmacology Unit
Start Date
2016-07
Trial ID
NCT03060044
Spacers are used by people with respiratory diseases who have problems usin...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03
Trial ID
NCT00369993
Treatments Being Tested
The aim of the current study is to compare the efficacy and safety of Salme...
Status
Terminated
Location
Akdeniz University Faculty of Medicine, Chest Diseases Department
Start Date
2018-04-13
Trial ID
NCT03363503
Treatments Being Tested
The purpose with this study is to describe in detail the control or lack of...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-02
Trial ID
NCT00858286
Treatments Being Tested
The purpose of this study is to evaluate whether beclomethasone dipropionat...
Status
Completed
Location
Optimum Patient Care
Start Date
2008-01
Trial ID
NCT01242098
Asthmatic children who remain symptomatic on inhaled corticosteroids (ICS) ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-11-04
Trial ID
NCT00315744
Treatments Being Tested